ALL-676 Blinatumomab With Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Autor:	Aleid, Manar, Alrajhi, Abdullah, Alwadi, Mohammad, Alsugair, Ali, Alshehri, Hassan, Tailor, Imran K., Hanbali, Amr, Alfraih, Feras Abdulaziz, Alhayli, Saud, Alahmari, Ali, Albabtain, Abdulwahab, Alotaibi, Ahmad S., Alnoamani, Mohammed S., Alshehry, Nawal F., Motabi, Ibraheem H., Alzahrani, Hazza A., Marei, Mohammed A., Saad, Ayman, Aljurf, Mahmoud, Fakih, Riad El, Alhumaid, Muhned, Alfayez, Mansour
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S280-S280
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect